Search clinical trials for: glucagon-like peptide-1

Total 48169 results

University of Chicago

Completed

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
National Institute of Mental Health (NIMH)

Completed

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

HIV Infections | Cognition Disorders

United States
Eli Lilly and Company

Completed

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Beckman Coulter, Inc.

Completed

Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

Heart Failure

United States
Inge Marie Svane

Completed

Dual Vaccine Trial in Myeloproliferative Neoplasms

Polycythemia Vera | Essential Thrombocythemia

Denmark
Federal University of Vicosa
United States Agency for International Development (USAID); Coordenação de... and other collaborators

Completed

Peanuts Second Meal Glycemic Response

Type 2 Diabetes Mellitus

Brazil
Hoffmann-La Roche

Completed

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Diabetes Mellitus Type 2

Australia, United States, France, Germany, Mexico, Puerto Rico, Peru
University Hospital, Gentofte, Copenhagen
Merck Sharp & Dohme LLC

Completed

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Denmark
Cambridge University Hospitals NHS Foundation Trust

Completed

Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers (COCOA)

Cardiovascular Diseases

United Kingdom
Darier

Unknown

Safety and Efficacy Comparison of Minocycline Microgranules Versus Lymecycline in the Treatment of Mild to Moderate Acne (MXMIN-001)

Mild to Moderate Acne

Mexico
University of Arkansas

Completed

A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions

Cervical Intraepithelial Neoplasia

United States
National Cancer Institute (NCI)

Completed

AMG 386 and Abiraterone for Advanced Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Neoplasm, Prostate | Neoplasm,Prostatic

United States
Children's Hospital Medical Center, Cincinnati
National Center for Research Resources (NCRR)

Completed

A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks

Sleep Apnea | Sleep Disordered Breathing

United States
University Hospital, Gentofte, Copenhagen

Completed

GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake (GASOLIN)

Obesity | Type 2 Diabetes | Adiposity

Denmark
Tianjin Medical University Cancer Institute and...

Recruiting

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Breast Cancer

China
Royal Devon and Exeter NHS Foundation Trust
King's College London; Leiden University Medical Center

Completed

Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin Production (TIGI)

Type 1 Diabetes Mellitus

Netherlands, United Kingdom
Massachusetts General Hospital

Withdrawn

Testosterone Regulation of the Natriuretic Peptide System

Hypertension
Yang Tao

Completed

Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes

Type 1 Diabetes

China
Chinese PLA General Hospital

Unknown

GLP-1 on Non-ST-Segment Elevation Myocardial Infarction

Myocardial Infarction

China
Taipei Veterans General Hospital, Taiwan

Completed

A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects (IC-1-V1)

Healthy

Taiwan
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

Cardiovascular Diseases | Diabetes Mellitus | Insulin Sensitivity/Resistance | Metabolic Disease | Energy Expenditure | Metabolism | Natriuretic Peptides

United States
Lindenwood University
Ingenious Ingredients, L.P.

Completed

Dileucine and Resistance Training Adaptations (DTS)

Hypertrophy | Strength Training Adaptations | Weight-Bearing Strengthening Program

United States
Dr. C. Bonorino Udaondo Gastroenterology Hospital

Completed

AN-PEP on Gluten Exposure in Celiacs

Celiac Disease

Argentina
Danish Headache Center
EUROHEAD

Completed

Calcitonin Gene Related Peptide-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2.

Familial Hemiplegic Migraine

Denmark
Suleyman Demirel University

Recruiting

Developing a New Scale for Evaluating Shoulder Problems

Shoulder Injuries | Shoulder Pain | Shoulder Lesions

Turkey
Lars Møller Pedersen

Completed

Peptide Vaccination Against PD-L1 and PD-L2 in Relapsed Follicular Lymphoma

Follicular Lymphoma

Denmark
Rigshospitalet, Denmark

Completed

Glucolipotoxicity and Type 2 Diabetes

Type 2 Diabetes Mellitus

Denmark
University Hospital, Gentofte, Copenhagen

Completed

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea (HNF1A-Clamp)

Maturity-Onset Diabetes of the Young, Type 3

Denmark
Exsulin Corporation

Terminated

Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

Type 1 Diabetes Mellitus

United States, Canada
EZUS-LYON 1

Active, not recruiting

CARdioprotection in Myocardial Infarction (CARIM)

Myocardial Infarct

France
EZUS-LYON 1

Active, not recruiting

The Influence of Manual Therapy Applied to the Cervical Spine in the Prevention of Balance Disorders in the Elderly (ManEq)

Elderly | Gait | Balance, Postural

France
Sanofi

Completed

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure (GAUDI)

Type 2 Diabetes Mellitus

Japan
Methodist Health System

Not yet recruiting

Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy

Polycystic Ovary Syndrome

United States
Novo Nordisk A/S

Completed

A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants

Healthy Participants

Germany
Baylor Health Care System
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
University of Copenhagen
EC-FP6 (contract number: LHM-CT-2003-503041); Aditech Pharma AB

Completed

The Role of Peptide YY (PYY)Infusions in Inhibiting Food Intake.

Obesity
University of Chicago

Terminated

Trial of G250 Peptide and IL-2 Following Surgical Resection of Locally Advanced/Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma and other conditions

United States
Novo Nordisk A/S

Completed

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice

Diabetes Mellitus, Type 2

Mexico
Novo Nordisk A/S

Completed

Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

Chile
Capricor Inc.

Completed

Safety Study of Cenderitide in Stable Chronic Heart Failure

Heart Failure

United States
Assistance Publique - Hôpitaux de Paris

Completed

Effect of GLP-1 on Angiogenesis (ANGIOSAFE 1)

Type 2 Diabetes

France
Herlev Hospital
Merck Sharp & Dohme LLC; University of Copenhagen; Diabetesforeningen; Forsknin...

Completed

Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes

Incretin Effect

Denmark
National Institute of Diabetes and Digestive and...
Pfizer

Recruiting

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Diabetes Mellitus, Type 1

United States
The University of Texas Health Science Center,...

Completed

Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists

Pulmonary Aspiration

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Improvement of Live Babies Rates After ICSI, Using cpFT (FERTICSI)

Infertility | Pregnancy | Oocyte

France
National Cancer Institute (NCI)

Completed

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Melanoma | Neoplasm Metastasis

United States
Charite University, Berlin, Germany

Unknown

WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Germany
Charite University, Berlin, Germany

Unknown

WT1 Peptid Vaccination in Carcinomas

WT1 Expressing Carcinoma

Germany
Hasan Kalyoncu University

Recruiting

Study of the Effect of Compassion-Based Education Program Applied to Mothers of Children Diagnosed With Cerebral Palsy

Cerebral Palsy

Turkey

Search clinical trials for: glucagon-like peptide-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations